what is Low dose immunotherapy?

An introduction to Low Dose Immunotherapy

Low Dose Immunotherapy (LDI) represents a pioneering strategy for managing allergies and autoimmune disorders by gradually training the immune system to respond appropriately. In contrast to conventional treatments, LDI is considered safer and effective across a broader spectrum of conditions, with a reduced risk of adverse reactions. The therapy is administered sublingually, which helps avoid the discomfort often linked with injections. It utilizes significantly lower doses, making it a more convenient option for patients. The frequency of treatment is typically less than traditional approaches and can be adjusted based on the patient's progress. LDI provides a promising alternative for individuals who have not achieved satisfactory results with other therapies, with the goal of achieving sustained, long-term symptom relief.